Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and Prophylaxis

Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Regulation of Karyopherin α1 and Nuclear Import by Mammalian Target of Rapamycin

(2012) Jill A. Fielhaber et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts

(2012) Ayiasha Pratt et al.   MEDICAL MYCOLOGY

Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis

(2011) P. Campoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Improved Model of the Aspergillus fumigatus CYP51A Protein

(2011) M. G. Fraczek et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration

(2011) Anders Lignell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular mechanism of Aspergillus fumigatus adherence to host constituents

(2011) Donald C Sheppard   CURRENT OPINION IN MICROBIOLOGY

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

(2010) A. H. Groll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients

(2010) J. E. Conte et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral Blood

(2010) F. Farowski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-  Demethylase (CYP51) Isoenzymes A and B

(2010) A. G. S. Warrilow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current therapeutic approaches to fungal infections in immunocompromised hematological patients

(2010) Livio Pagano et al.   BLOOD REVIEWS

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole

(2010) Chiung-Kuang Chen et al.   PLoS Neglected Tropical Diseases

Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi

(2010) Bryce E. Mansfield et al.   PLoS Pathogens

The innate immune response to Aspergillus fumigatus

(2009) Viviane Balloy et al.   MICROBES AND INFECTION

Antifungal Therapy for Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Recipients: An Update

(2009) Dustin T. Wilson et al.   MYCOPATHOLOGIA

Recent Advances in Antifungal Prevention and Treatment

(2009) Andreas H. Groll et al.   SEMINARS IN HEMATOLOGY

Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects

(2008) J. E. Conte et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transcriptional Profiling Identifies a Role for BrlA in the Response to Nitrogen Depletion and for StuA in the Regulation of Secondary Metabolite Clusters inAspergillus fumigatus

(2008) Kwame Twumasi-Boateng et al.   EUKARYOTIC CELL